News
AcuraBio Head of Science & Technology at CPHI to Discuss Australia’s CDMO Opportunities for European Biotechs
Dr. Tim Evans, AcuraBio’s Chief Scientific Officer will share how Australia offers clinical stage biotechs the world’s most attractive financial and regulatory incentives.
News
AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program
Brisbane, Australia – 18 October 2022 – AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, recently acquired by biotech...
News
Meet with AcuraBio at BioJapan Booth #D-26
Brisbane, Australia – 12 October 2022 – AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, is at BioJapan to...
News
Acquisition announcement
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding Company as AcuraBio Brisbane, Australia –...
News
Helping to develop a low-cost vaccine for Helicobacter pylori (Case Study)
AcuraBio is helping a leading Australian children’s health charity to develop a vaccine for Helicobacter pylori, a bacterial infection that...
